ClinicalTrials.gg
RecruitingNCT07127939Updated Nov 20, 2026

Diagnostic Performance of an AI-based Model for TCM Constitution Classification Using Ophthalmic Imaging

An observational study in Ophthalmic Imaging, Deep Learning and Artificial Intelligence (AI), sponsored by Second Affiliated Hospital of Nanchang University. Recruiting at 1 site in China. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Second Affiliated Hospital of Nanchang University · Observational

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,024
Ages
18 Years to 45 Years
Sex
All
01

Study summary

To evaluate the diagnostic performance of a multimodal deep learning model for identifying biased Traditional Chinese Medicine (TCM) constitutions using ophthalmic imaging

Read the detailed description

The identification of Traditional Chinese Medicine (TCM) constitutions is a central principle of its preventive medicine philosophy (Zhi Wei Bing). Yet, current diagnostic methods-relying on subjective questionnaires and expert interpretation-are not scalable, objective, or efficient enough for widespread clinical use. While artificial intelligence has been applied to traditional inputs like tongue and pulse analysis, these approaches have failed to overcome fundamental issues of data standardization and objectivity. Consequently, a critical gap exists: there is no modern, reliable, and scalable tool to assess TCM constitutions, preventing the full integration of this valuable theory into contemporary healthcare.

This study aims to bridge that gap by developing and validating a novel deep learning model for "intelligent ocular diagnosis" of TCM constitutions. By using highly objective and information-rich ophthalmic imaging, our approach circumvents the subjectivity inherent in traditional methods. The primary objective is to create a fully automated, high-throughput system capable of accurately classifying TCM constitutions. The successful completion of this project will not only provide the first objective tool for TCM constitution analysis but will also establish a powerful framework for the early prediction and personalized management of chronic diseases, creating a new paradigm for integrated Chinese and Western medicine.

02

Conditions studied

  • Ophthalmic Imaging
  • Deep Learning
  • Artificial Intelligence (AI)
  • Traditional Chinese Medicine Constitution

Keywords

  • Ophthalmic Imaging
  • Deep Learning
  • Artificial Intelligence
  • Traditional Chinese medicine constitution
03

In context

Lead sponsor

Second Affiliated Hospital of Nanchang University is the lead sponsor of 85 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Chronic systemic disease patients and healthy subjects from the Second Affiliated Hospital of Nanchang University.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: Participants aged between 18 and 60 years;
  2. Chronic Systemic Diseases: Defined according to the standards of the United States National Center for Chronic Disease Prevention and Health Promotion and the "Healthy China 2030" planning outline issued by the State Council. These are characterized as conditions lasting one year or longer that require continuous medical care, limit daily activities, or both. The four major chronic diseases in China include:Cardiovascular and cerebrovascular diseases,Malignant neoplasms,Diabetes mellitus and Chronic respiratory diseases;
  3. Cardiovascular and Cerebrovascular Diseases: This category includes:Hypertension: Stable hypertension without acute episodes, defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or currently undergoing antihypertensive treatment.Coronary Heart Disease: Diagnosed based on a history of coronary heart disease or confirmed through imaging evidence such as coronary angiography or CT angiography.

    Heart Failure: Classified as (NYHA) functional class II-IV with a \<40%.Stroke: Diagnosed based on a history of ischemic or hemorrhagic stroke or confirmed through imaging evidence such as MRI or CT scans;

  4. Malignant Neoplasms: Participants with newly diagnosed, recurrent, malignant tumors, or those currently receiving specific treatments (e.g., chemotherapy, radiotherapy, immunotherapy), confirmed by histological or cytological examinations;
  5. Diabetes Mellitus: Participants meeting at least one of the following criteria:

    Fasting blood glucose ≥7.0 mmol/L (126 mg/dL),2-hour post-oral glucose tolerance test blood glucose ≥11.1 mmol/L (200 mg/dL), ≥6.5%,Random blood glucose ≥11.1 mmol/L (200 mg/dL) accompanied by typical symptoms (e.g., polydipsia, polyuria, weight loss);

  6. Chronic Respiratory Diseases: This category includes: (COPD): Post-bronchodilator /FVC \<0.70 and FEV₁ \<80% of the predicted value, accompanied by at least one clinical symptom such as chronic cough, sputum production, or dyspnea.Asthma: Reversible airflow limitation, defined as a post-bronchodilator FEV₁ increase of ≥12% and ≥200 ml, accompanied by at least one clinical symptom such as recurrent wheezing, dyspnea, chest tightness, or cough;
  7. Healthy Subjects: Individuals who have not experienced any systemic diseases within the past year that require continuous medical care, limit daily activities, or both;
  8. Clear Diagnosis Based on Traditional Chinese Medicine and Western Medicine: Participants must have a definitive diagnosis established through both Traditional Chinese Medicine and Western Medicine methodologies;
  9. Absence of Other Ocular or Systemic Organic Diseases: Participants should have no other ocular diseases and/or systemic organic lesions that significantly affect the acquisition of ocular imaging.

Exclusion criteria

Exclusion Criteria:

  1. Incomplete Clinical Data Supporting Diagnosis: Participants for whom the clinical data necessary to substantiate the diagnosis are incomplete;
  2. Significant Opacification of Other Ocular Optical Systems: Individuals presenting with pronounced obscurations in other ocular optical systems (e.g., severe corneal opacification, nuclear cataract grade IV or higher, severe vitreous hemorrhage or opacification) that impede the completion of comprehensive ocular examinations;
  3. Acute Systemic Organic Diseases: Patients concurrently suffering from acute systemic organic conditions (such as acute infections or decompensated organ failure) that prevent participation in the constitution identification procedures;
  4. Pregnancy or Lactation: Individuals who are pregnant or currently breastfeeding.
Terms in these criteria, in plain language(6)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,024 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with Chronic Systemic Diseases

    This cohort consists of participants with a confirmed diagnosis of one or more chronic systemic diseases. These include cardiovascular diseases, malignant tumors, diabetes mellitus, and chronic respiratory diseases, as defined by the study's inclusion criteria.

    Diagnostic Test: AI-based Ocular Diagnosis Model for TCM Constitutions

  • Healthy Control Group

    This cohort consists of volunteers with no history of major chronic systemic diseases. Participants are confirmed to have no conditions requiring continuous medical intervention or causing limitation of daily activities, serving as the control group for this study.

    Diagnostic Test: AI-based Ocular Diagnosis Model for TCM Constitutions

Interventions

  • Diagnostic testAI-based Ocular Diagnosis Model for TCM Constitutions

    AI-based Ocular Diagnosis Model for Identifying Traditional Chinese Medicine (TCM) Constitutions

06

What researchers measure

Primary outcomes

  1. AUROC of AI-based model in identifying TCM Constitutions

    The area under the receiver operating characteristic of AI-based model in identifying Traditional Chinese Medicine constitutions

    Time frame: Day 0

Secondary outcomes

  1. Sensitivity and specificity of AI-based model in identifying TCM Constitutions

    Sensitivity and specificity of AI-based model in identifying Traditional Chinese Medicine constitutions

    Time frame: Day 0

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2025 (actual). Primary completion is estimated for Dec 2028, 41 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2025
First posted
Aug 17, 2025
StartActual
Jul 1, 2025
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07127939
Lead sponsor
Second Affiliated Hospital of Nanchang University
Responsible party
Jian Xiong (Associate research fellow; Attending physician, Second Affiliated Hospital of Nanchang University) — Principal investigator
First posted
Aug 17, 2025
Start date
Jul 1, 2025
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 20, 2026

Study contacts

Jiang Xiong
Contact
894040417@qq.com
+8618170906556

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion